Zachary Veres, DO
Family Medicine · Warren, OHNPI 1285619239
Payments from drug & device makers
Across 90 payments — averaging $17.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$160
- AbbVie$152
- AstraZeneca$114
- Otsuka America Pharmaceutical, Inc.$107
- Pfizer$105
- Convatec Inc.$102
- plus $828 from 23 others
What the payments were for
- Food & beverage$1,566100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $160 |
| AbbVie | 9 | $152 |
| AstraZeneca | 8 | $114 |
| Otsuka America Pharmaceutical, Inc. | 4 | $107 |
| Pfizer | 6 | $105 |
| Convatec Inc. | 3 | $102 |
| Astellas Pharma US Inc | 5 | $99 |
| Indivior Inc. | 5 | $91 |
| Novo Nordisk | 4 | $63 |
| Axsome Therapeutics, Inc. | 2 | $59 |
| GSK | 4 | $57 |
| Biohaven Pharmaceuticals, Inc. | 3 | $50 |
| Amarin Pharma, Inc. | 3 | $46 |
| E.r. Squibb & Sons, L.L.C. | 2 | $38 |
| Novartis | 2 | $36 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $32 |
| Nestle Healthcare Nutrition Inc. | 2 | $30 |
| Johnson & Johnson | 2 | $30 |
| Sunovion Pharmaceuticals Inc. | 4 | $24 |
| Lundbeck LLC | 1 | $24 |
| Alkermes, Inc. | 1 | $21 |
| Braeburn Inc. | 1 | $21 |
| Paratek Pharmaceuticals, Inc. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Medtronic | 1 | $15 |
| Gilead | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
| Abbott | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
How this compares
$1,566 in reported general payments places this provider in the 70th percentile of 3,983 family medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 534 | $213,092 |
| JardianceEmpagliflozin | 109 | $56,141 |
| GlatopaGlatiramer Acetate | 11 | $49,987 |
| OzempicSemaglutide | 27 | $43,164 |
| FarxigaDapagliflozin Propanediol | 55 | $37,549 |
| JanuviaSitagliptin Phosphate | 36 | $31,997 |
| XareltoRivaroxaban | 51 | $25,717 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 34 | $25,173 |
| TrulicityDulaglutide | 21 | $21,201 |
| TradjentaLinagliptin | 34 | $19,656 |
| Rivastigmine | 74 | $18,404 |
| JanumetSitagliptin Phos/Metformin Hcl | 34 | $18,014 |
| GemtesaVibegron | 74 | $17,994 |
| AuvelityDextromethorphan Hbr/Bupropion | 26 | $13,828 |
| Spiriva HandihalerTiotropium Bromide | 18 | $13,725 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $105 | $213,092534 claims |
| AstraZenecaFarxiga, Lokelma, Breztri Aerosphere, Symbicort | $114 | $64,841125 claims |
| Novo NordiskOzempic | $63 | $43,16427 claims |
| Johnson & JohnsonXarelto, Procrit | $30 | $34,92068 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $57 | $32,14051 claims |
| Lilly USA, LLCTrulicity | $14 | $21,20121 claims |
| Axsome Therapeutics, Inc.Auvelity | $59 | $13,82826 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $107 | $11,57311 claims |
| AbbVieLinzess | $152 | $11,01319 claims |
| NovartisEntresto | $36 | $10,56719 claims |
| Astellas Pharma US IncMyrbetriq | $99 | $9,58425 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in Warren
- Jason RupekaWarren$77K
- Michael ButcherCincinnati$18.3M
- William RandallKettering$7.5M
- Paul NugentCincinnati$4.9M
- Steve ChoiDayton$4.8M
- Martin SchearDayton$2.2M
- Rajesh DavitCincinnati$2M
- Kwabena OtengSpringdale$2M
- Blaise GattoMoraine$1.8M
- Cathy GreiweColumbus$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.